The prognosis and optimal management of patients with endometrial cancer with low-volume lymph node metastases remains unclear, particularly, regarding the role of molecular classification.
This study investigates the distribution and prognostic role of molecular classes in this cohort of patients, while reviewing existing literature on this topic.
